Trials / Completed
CompletedNCT03930212
Progesterone Supplementation in Threatened Abortion
Progesterone Supplementation in Threatened Abortion: Is it a Sound Practice?
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 190 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
To decide whether progesterone supplementation in threatened abortion is a sound practice.
Detailed description
This study was conducted at Obstetrics and Gynecology Department, Tanta University in the period from January 2018 to December 2018. Patients: Eligible patients (n=190) were randomly allocated into 2 groups; study group who will receive progesterone supplementation (Prog.group) and control group who will receive no treatment (place.group).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Progesterone | received rectal progesterone suppositories 400 mg once daily |
| DRUG | Placebos | received placebo suppositories rectally once daily. |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2018-12-31
- Completion
- 2018-12-31
- First posted
- 2019-04-29
- Last updated
- 2023-07-18
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03930212. Inclusion in this directory is not an endorsement.